Talis Biomedical Co. (NASDAQ:TLIS – Get Free Report)’s stock price traded up 77.5% during mid-day trading on Thursday . The stock traded as high as $2.84 and last traded at $2.84. 59,306 shares traded hands during mid-day trading, an increase of 2,761% from the average session volume of 2,073 shares. The stock had previously closed at $1.60.
Talis Biomedical Stock Performance
The firm has a fifty day simple moving average of $1.63 and a 200 day simple moving average of $1.52. The company has a market capitalization of $5.18 million, a PE ratio of -0.10 and a beta of 1.32.
About Talis Biomedical
Talis Biomedical Corporation operates as a molecular diagnostic company, focusing on developing medical devices for infectious diseases and other conditions at the point of care in the United States. Talis Biomedical Corporation was incorporated in 2013 and is headquartered in Chicago, Illinois.
Featured Stories
- Five stocks we like better than Talis Biomedical
- About the Markup Calculator
- Broadcom Stock Crashes 20%—But Wall Street Sees It Soaring to $500
- Are Penny Stocks a Good Fit for Your Portfolio?
- Forget the Chips: 4 Industrial Plays for the AI Rebound
- What is a Secondary Public Offering? What Investors Need to Know
- MongoDB Could Hit Record Highs—But You’ll Need to Move Fast
Receive News & Ratings for Talis Biomedical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Talis Biomedical and related companies with MarketBeat.com's FREE daily email newsletter.
